In-House Manufacturing Phamatech's unique capability to manufacture its own rapid testing products domestically positions it as a reliable supplier for clients seeking high-quality, certified diagnostic solutions, making it an attractive partner for laboratories and healthcare providers looking for consistent quality and supply chain security.

Comprehensive Certification With accreditations including SAMHSA, CAP-FDT, CLIA, and ISO, Phamatech demonstrates a strong commitment to quality standards, appealing to institutions that prioritize compliance and accuracy in drug and diagnostics testing—key factors for expanding sales within regulated healthcare markets.

Product Diversification Offering a broad portfolio that includes DNA drug testing, rapid test products, and home health testing, Phamatech provides multiple avenues for sales engagement, especially with organizations seeking integrated testing solutions or remote testing options.

Recent COVID-19 Response The launch of on-location COVID-19 PCR and antibody testing reflects adaptability to emerging health crises, opening opportunities to partner with healthcare facilities, employers, and schools that require reliable, rapid COVID-19 testing services for safe operations.

Growth & Market Presence With revenue between $50 million and $100 million and a staff of up to 200 employees, Phamatech is a mid-sized player poised for growth, signaling potential for expanding product lines or entering new regional markets through strategic partnerships and targeted sales efforts.